Abbott (NYSE:ABT) today shared new clinical trial findings supporting its Aveir AR leadless atrial pacemaker system.

AMSTERDAM, the Netherlands—In patients with sinus node dysfunction treated with dual-chamber pacemakers, minimizing atrial pacing doesn’t lower the likelihood of developing atrial fibrillation (AF) ...

Single-chamber ventricular leadless pacemakers do not support atrial pacing or consistent atrioventricular synchrony. A dual-chamber leadless pacemaker system consisting of two devices implanted ...

Please provide your email address to receive an email when new articles are posted on . Rate-modulated pacing at 60 bpm did not reduce AF incidence vs. nonadaptive pacing at 40 bpm in patients with ...

Minimizing atrial pacing does not prevent atrial fibrillation in patients with sinus node dysfunction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.

AMSTERDAM -- Reducing atrial pacing didn't help prevent atrial fibrillation (Afib, or AF) in patients with sinus node dysfunction but did increase risk of fainting, the DANPACE II trial showed. The ...

Amsterdam, Netherlands – 28 Aug 2023: Minimising atrial pacing does not prevent atrial fibrillation in patients with sinus node dysfunction, according to late breaking research presented in a Hot Line ...

Minimizing atrial pacing does not alter the risk of atrial fibrillation (AF) associated with sinus node dysfunction (SND), suggest results of a trial that randomly assigned patients with SND who had ...

Treatment of supraventricular arrhythmias varies according to rhythm, rate, and hemodynamic stability. Therapeutic modalities include pharmacologic therapy, electrical cardioversion, ablation, and/or ...

Last week, Abbott began the commercial launch of its new leadless pacemaker, which it believes is a historic development in the world of cardiac rhythm devices. Aveir DR is a better option than ...

NEW ORLEANS -- A leadless dual-chamber pacemaker with bidirectional wireless communication turned in very promising short-term results in patients with standard indications for dual-chamber pacing, ...

NEW ORLEANS, LA—Rate-adaptive atrial pacing to increase heart rate during exercise is not a useful strategy in patients who have heart failure with preserved ejection fraction (HFpEF) and chronotropic ...